Subpart A Subcommittee and Subcommittee on Harmonization recommendations for the revised Common Rule and related discussions

Supplemental biologics license application or mepolizumab for injection, submitted by GlaxoSmithKline for add-on treatment to inhaled corticosteroid-based maintenance treatment for the reduction of exacerbations in patients with chronic obstructive pulmonary disease (COPD) guided by blood eosinophil counts

Remoxy ER (oxycodone extended-release capsules), submitted by Pain Therapeutics

Presentations on CBER Research Programs